Nuestros blogs explican las afecciones de salud y la investigación clínica de una manera fácil de entender, para que los lectores se sientan más informados.
Regeneron vision drug Eylea sees upward tick in unexplained side-effect cases
Regeneron’s eye drug Eylea has been a hit on the market for years. But now, the number of patients experiencing a rare side effect is climbing, and doctors don’t know why. Post-injection, some patients experience a sharp decline in sight and...
Adaptive Genetic Mutations Detected with Innovative Software
Researchers from Brown University have developed a new method for sifting through genomic data in search of genetic variants that have helped populations adapt to their environments. The technique, dubbed SWIF(r), could be helpful in piecing together the evolutionary history of...
Body’s Own Stem Cells Could Serve as Cancer Vaccine
Induced pluripotent stem cells, or iPS cells, are a keystone of regenerative medicine. Outside the body, they can be coaxed to become many different types of cells and tissues that can help repair damage due to trauma or disease. Now, a...
New Lung Probe Technology Speeds Infection Detection
A medical imaging technology under development has enabled doctors to see bacteria deep inside patients’ lungs for the first time. Early tests indicate the bedside technology may be able to detect harmful bacteria in patients’ lungs in less than 60 seconds....
Infección común y mortal por hongos diagnosticada más rápidamente con un análisis de sangre
A new blood test seems to perform as well as, if not better than, traditional blood cultures at detecting a type of fungal yeast infection that commonly strikes hospital patients, according to an analysis led by UPMC. The T2Candida Panel is...
Una proteína específica podría reducir la inflamación y mejorar la supervivencia durante la gripe.
UNIVERSITY PARK, Pa. — GM-CSF, a protein that modifies the immune response to the Influenza Treatment, may also help reduce lung inflammation and improve survival during influenza, according to Penn State researchers. The researchers studied the survival and lung function of...
ID’ing Features of Flu Virus Genome May Help Target Surveillance for Pandemic Flu
Pandemic flu occurs when flu strains from different species – birds and humans, or humans and pigs – genetically mix to make a new virus that spreads faster and makes people sicker than either strain alone. Public health authorities monitor places...
Artificial Sweetener Could Offer Superior Cancer Treatments
Artificial sweeteners are used in diet drinks and foods but also could someday be used as treatments targeting carbonic anhydrase IX (CA IX), a protein associated with aggressive cancers. Although several drugs have been approved that target similar forms of CA,...
Las distintas mutaciones humanas pueden alterar el efecto de los medicamentos.
Effects of the medicine may alter by the Distinct Human Mutations. Every person has a unique DNA sequence. In a new study published in the scientific journal Cell, they look at certain receptors (GPCRs) in human cells. These protein receptors are the main...
Tuberculosis Drugs Work Better With Vitamin C
Studies in mice and in tissue cultures suggest that giving vitamin C with tuberculosis drugs could reduce the unusually long time it takes these drugs to eradicate this pathogen. In the study, the investigators treated Mycobacterium tuberculosis-infected mice with anti-tuberculosis drugs...
FDA Permits Marketing of Device to Treat Diabetic Foot Ulcers
The FDA Last week permitted the Marketing of Dermapace System, the first shock device to treat Diabetic Foot ulcers. “Diabetes is the leading cause of lower-limb amputations,” said Binita Ashar, M.D., director of the division of surgical devices in FDA’s Center...
FDA again delays Portola’s BLA for bleeding antidote
The bleeding Antidotes have been delay again by FDA. Portola Pharmaceuticals is faced with getting its AndexXa universal bleeding reversal agent considered for approval by the FDA. Pfizer and Bristol-Myers Squibb, as well as Bayer and Johnson & Johnson, were hoping...